Main Article

Only two years after receiving $50 million in equity financing from Water Street Healthcare Partners in May 2006, Lakewood Pathology Associates has refined its platform business—genitourinary (GU) pathology—and is now entering the gastrointestinal (GI) pathology market, currently valued at between $1 billion and $1.5 billion in the United States. The company is also undergoing a rebranding—as of August 4, the Lakewood, New Jersey-based pathology group will be renamed PLUS Diagnostics.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

August 2008 - Table of Contents

LIR August 2008 (full PDF issue)

Medicare Bill Delivers 4.5% Lab Fee Update in 2009, Repeals Competitive Bidding Demo

Global M&A Market Totals Over $300 Million Through First Half of 2008

GE Healthcare Dives Into $2-$4 Billion Digital Pathology Market

John Muir’s Strategies for Outreach Growth Leads to $35 Million New Lab

Lakewood Pathology Enters $1 Billion GI Testing Market, Renamed PLUS Diagnostics

Calif. Cease-and-Desist Letters Spark Fear in DTC Testing Industry

Lab Stocks Continue to Show Strength; Index up 13% Over 13 Weeks

Nearly Half of Labs Struggle to Fill Med Tech Positions

Global M&A Market Totals Over $300 Million Through First Half of 2008